Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NONOF Forum: Aktien User: Coronaprofiteur

im Zusammenhang mit Sport befürwortet er es wohl habe ich kürzlich gelesen.

Na dann 😂

https://www.yahoo.com/news/rfk-jr-power-means-vaccines-191051529.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAMTrbOQxXl6_0XT9enu-tQKqsqzZ_fU4GZ4N6Y9HERuclZzNwOs6D7xFWEj_UwO3WN-5ITfAVetqKerZF1nitZIPzEdf3mHDmNDOy-UHMp_0-NWWdPG7ziZoS815liEFsE6sXVTx37A8zKKDYDKZTFebk-Egj5ZBumxVI7ZH_ogO

ich mein im Grunde hat er ja Recht. Kann man nicht abstreiten.... Ich würde mir diese Spritze auch nicht laufend setzen wollen. Warum kostet die in USA eig viel mehr als in Dtld.? Das ist doch auch ne Frechheit.

Auszug Kennedy and his MAHA circle are not fans of the weight-loss drugs that have become hugely popular and supercharged shares of Zepbound maker Eli Lilly & Co. and Denmark’s Novo Nordisk A/S, the maker of Ozempic and Wegovy. “When I’m working in the next administration, I will address our sick food system — and the corrupt government agencies — to help make our country healthy again,” Kennedy wrote on X before the presidential election. “In the meantime, perhaps we should consider replanting the kitchen garden before sending more money to Denmark,” he said. Kennedy later walked back those remarks, saying in a CNBC interview that the drugs “have a place,” but that the first line of defense against obesity and other chronic diseases “should be lifestyle, it should be eating well.” If Kennedy were to attempt to revoke approvals for Ozempic and other drugs like it, known as GLP-1s, it’d likely be a legal nightmare. But he could move to limit access to the medications. Last year, the Biden administration issued a proposal to cover obesity drugs through Medicare, the government health insurance program for people 65 and older. The onus is on the Trump administration to finalize it. ADVERTISEMENT Calley Means, a health entrepreneur and top Kennedy adviser, has railed against the popularity of Ozempic and criticized the Biden administration’s proposal. At the same time, Elon Musk, a close Trump adviser, has touted the benefits of weight-loss drugs, going so far as to say “nothing would do more to improve the health, lifespan and quality of life for Americans” than making GLP-1 drugs “super low cost to the public.” It’s an important issue for Lilly and Novo, who are still pushing the Trump administration to finalize the rule. Another key figure in decisions on Medicare reimbursement for the drugs is Mehmet Oz, the celebrity doctor whom Trump picked to lead the Centers for Medicare and Medicaid Services. “My argument to Mehmet Oz is that if you want to protect Medicare costs in 10 years, have ACA and Medicare plans list these drugs now,” Lilly CEO Dave Ricks said in an interview with Bloomberg in January, referring to the Affordable Care Act. “We know so much about how much cost savings there will be downstream in heart disease and other conditions.” Ricks is also asking the Trump administration to crack down on the booming market for copycat weight-loss drugs. So-called compounding pharmacies have capitalized on a legal policy that allows copies of drugs to be made when the brand-name ones are in shortage. Widespread shortages of Novo and Lilly’s drugs last year allowed cheaper, copycat versions to proliferate. ADVERTISEMENT Ricks has blamed the Biden administration for not doing enough to stop it. “We’re counting on the new administration to enforce this,” Ricks told Fox Business last week. However, there's signs it may not go the way pharma had hoped. “Our sense (reading in-between the lines), is that the RFK-led HHS will take a fairly lenient stance with respect to the GLP compounders provided the drugs are seen as safe,” Mizuho health-care sector specialist Jared Holz said in a note after Kennedy was confirmed, noting the recent rise in shares of Hims & Hers Health Inc., which sells compounded shots.

Schon aus November aber trotzdem CNN — Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect Donald Trump’s pick to lead the US Department of Health and Human Services. They’re goals that many in the public health world find themselves agreeing with — despite fearing what else the infamous anti-vaccine activist may do in the post. Just don’t suggest that he tackle those goals with medications like Ozempic. RFK Jr.’s to-do list to make America ‘healthy’ has health experts worried “They’re counting on selling it to Americans because we’re so stupid and so addicted to drugs,” Kennedy said in an appearance with Fox News’ Greg Gutfeld that he posted to Instagram last month, concluding that Ozempic, a wildly popular medicine approved to treat type 2 diabetes and used off-label for weight loss, is not going to “Make America Healthy Again.”

https://amp.cnn.com/cnn/2024/11/17/health/rfk-jr-ozempic

Also ich denke das nicht 😂

denkste die übergewichtigen Amerikaner machen dann jetzt alle auf einmal Sport oder wie? :D

Der ist generell nicht so für Abnehmspritzen. Der so Crazy keine Ahnung was da kommt

produziert novo aber denn nicht vor Ort? also Zölle sollten doch im Grunde nicht das Problem sein?

Glaube ja das man abwartet was Kennedy für einen Mist verzapfen wird

Novo ist wohl auch von den Zöllen betroffen. Für mich erstmal kein Kauf.

Bin jetzt investiert. Fairer Preis und gute Zukunftsaussichten. Börse ist für mich was langfristiges, selbst wenn es noch ein wenig fällt, bin ich immer noch günstiger dabei, als die ganzen Schwätzer die investieren, wenn der Kurs an einem Tag eine 8% Rakete zündet. In den Foren lese ich immer wieder, dass Leute meinen sie könnten den absoluten Tiefpunkt erkennen. Da kann ich nur sagen: viel Spaß mit eurer Strategie, das wird nicht möglich sein.

für den Doppelboden darf es aber nicht tiefer als es am 19.01. gewesen ist? bin ich da richtig? und dann müsst es zügig nach oben ausbrechen? Ohne irgendwelche Infos? Glaubt da irgendjemand hier dran?